ATE551065T1 - Zusammensetzungen mit igbpma und ihre verwendungen - Google Patents

Zusammensetzungen mit igbpma und ihre verwendungen

Info

Publication number
ATE551065T1
ATE551065T1 AT06808355T AT06808355T ATE551065T1 AT E551065 T1 ATE551065 T1 AT E551065T1 AT 06808355 T AT06808355 T AT 06808355T AT 06808355 T AT06808355 T AT 06808355T AT E551065 T1 ATE551065 T1 AT E551065T1
Authority
AT
Austria
Prior art keywords
igbpma
compositions containing
activation
agents
ticks
Prior art date
Application number
AT06808355T
Other languages
English (en)
Inventor
Hui Wang
Patricia Nuttall
Original Assignee
Natural Environment Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Environment Res Council filed Critical Natural Environment Res Council
Application granted granted Critical
Publication of ATE551065T1 publication Critical patent/ATE551065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT06808355T 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen ATE551065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0522298.9A GB0522298D0 (en) 2005-11-01 2005-11-01 Agents that bind IgE
PCT/GB2006/003986 WO2007051975A2 (en) 2005-11-01 2006-10-26 Compositions comprising igbpma and uses thereof

Publications (1)

Publication Number Publication Date
ATE551065T1 true ATE551065T1 (de) 2012-04-15

Family

ID=35516154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808355T ATE551065T1 (de) 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen

Country Status (7)

Country Link
US (1) US8343504B2 (de)
EP (1) EP1978990B1 (de)
JP (1) JP5123858B2 (de)
CN (1) CN101351216B (de)
AT (1) ATE551065T1 (de)
GB (1) GB0522298D0 (de)
WO (1) WO2007051975A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2534958A1 (de) 2007-12-14 2012-12-19 AeroDesigns, Inc Abgabe von Aerosol-sprühbaren Nahrungsmittelprodukten
GB201203337D0 (en) 2012-02-24 2012-04-11 Natural Environment Res Council Method
CN110567787A (zh) * 2019-09-12 2019-12-13 浙江工商大学 一种快速纯化血清中IgG和IgE的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406708D0 (en) * 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
ES2236807T3 (es) 1996-05-18 2005-07-16 Evolutec Limited Moleculas de union de aminas vasoactivas.
WO2001058941A1 (en) * 2000-02-11 2001-08-16 Evolutec Limited Cytokine activity regulator molecules from tick salivary glands
WO2002094228A1 (en) 2001-05-23 2002-11-28 David Follansbee Prevention and treatment of allergies by helminthic regulation of ige
GB0307544D0 (en) 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
AU2004309111B2 (en) * 2003-12-24 2011-02-24 Merck Serono Sa CC-chemokine-binding tick proteins

Also Published As

Publication number Publication date
JP2009519213A (ja) 2009-05-14
US8343504B2 (en) 2013-01-01
GB0522298D0 (en) 2005-12-07
EP1978990B1 (de) 2012-03-28
JP5123858B2 (ja) 2013-01-23
US20080280828A1 (en) 2008-11-13
CN101351216B (zh) 2014-07-16
WO2007051975A2 (en) 2007-05-10
CN101351216A (zh) 2009-01-21
WO2007051975A3 (en) 2007-06-28
EP1978990A2 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
ATE527365T1 (de) Il-15r alpha -sushi domäne als selektiver und effizienter verstärker der il-15-wirkung durch il-15rbeta/gamma , in hyperagonist il-15 ralpha sushi -il 15 fusionsproteine .
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE481984T1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
WO2006133134A3 (en) Compositions comprising elemental metals and uses therefor
ATE460923T1 (de) Lyophilisierung von virosomen
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
EA200870019A1 (ru) Лактамовые соединения и способы их применения
UA101301C2 (ru) ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ
ATE541928T1 (de) Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen
ATE554785T1 (de) Modifizierte fgf-21 polypeptide und ihre verwendung
ECSP109956A (es) Composiciones y métodos para controlar nemátodos
ATE516286T1 (de) 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
PL1922128T3 (pl) Element do zmniejszania zawartości drobnego pyłu w powietrzu, za pomocą mchów i/lub porostów
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
NO20093542L (no) Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
TW200833248A (en) Bisoximes as fungicides